Cargando…
Macrophage activity at the site of tumor ablation can promote murine urothelial cancer via transforming growth factor-β1
Cell death and injury at the site of tumor ablation attracts macrophages. We sought to understand the status and activity of these cells while focusing on transforming growth factor-β1 (TGF-β1), a potent immunosuppressive and tumorigenic cytokine. Patients with urothelial cancer who underwent ablati...
Autores principales: | Kimura, Yasushi, Fujimori, Masashi, Rajagopalan, Neeraj Raghuraman, Poudel, Krish, Kim, Kwanghee, Nagar, Karan, Vroomen, Laurien GPH., Reis, Henning, Al-Ahmadie, Hikmat, Coleman, Jonathan A., Srimathveeravalli, Govindarajan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902765/ https://www.ncbi.nlm.nih.gov/pubmed/36761730 http://dx.doi.org/10.3389/fimmu.2023.1070196 |
Ejemplares similares
-
Comparison of ablation defect on MR imaging with computer simulation estimated treatment zone following irreversible electroporation of patient prostate
por: Srimathveeravalli, Govindarajan, et al.
Publicado: (2016) -
Combined OX40 Agonist and PD-1 Inhibitor Immunotherapy Improves the Efficacy of Vascular Targeted Photodynamic Therapy in a Urothelial Tumor Model
por: Alvim, Ricardo G., et al.
Publicado: (2021) -
Modeling biological and genetic diversity in upper tract urothelial carcinoma with patient derived xenografts
por: Kim, Kwanghee, et al.
Publicado: (2020) -
Patient-Derived Xenograft Models in Urological Malignancies: Urothelial Cell Carcinoma and Renal Cell Carcinoma
por: Tracey, Andrew T., et al.
Publicado: (2020) -
Targeted Therapies in Advanced and Metastatic Urothelial Carcinoma
por: Katims, Andrew B., et al.
Publicado: (2022)